> Johnson & Johnson says it continues to believe in the positive benefit-risk profile of its COVID-19 vaccine

Johnson & Johnson says it continues to believe in the positive benefit-risk profile of its COVID-19 vaccine

Eamonn Sheridan

Eamonn Sheridan

Thursday, 15/04/2021 | 01:26 GMT-0

0

J&J says it has actively postponed launch of its vaccine in Europe (I posted on the pause in Europe yesterday)

Most Popular

Contact us
Newsletter

GMT 00:00:00

LON 00:00:00

NY 00:00:00

TKYO 00:00:00

SYD 00:00:00

Stock Daily Updates

Top Forex Brokers

ForexLive Premium

ForexLive Premium

Must Read

!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}